Search Results

ARRY-543 5mg 5mg  | Purity Not Available

Adooq Bioscience

ARRY-543 is a novel, oral ErbB family inhibitor that, unlike approved ErbB inhibitors, targets all members of the ErbB family, including ErbB3, either directly or indirectly, and has potential advantages in treating tumors that signal through multiple ErbB family members.

More Information Supplier Page

ARRY-543 50mg 50mg  | Purity Not Available

Adooq Bioscience

ARRY-543 is a novel, oral ErbB family inhibitor that, unlike approved ErbB inhibitors, targets all members of the ErbB family, including ErbB3, either directly or indirectly, and has potential advantages in treating tumors that signal through multiple ErbB family members.

More Information Supplier Page

Tafenoquine 10mg 10mg  | Purity Not Available

Adooq Bioscience

Tafenoquine is an 8-aminoquinoline drug manufactured by GlaxoSmithKline that is being investigated as a potential treatment for malaria, as well as for malaria prevention.

More Information Supplier Page

Letaxaban (TAK-442) 50mg 50mg  | Purity Not Available

Adooq Bioscience

Letaxaban, also known as TAK-442, is a potent, selective, and orally active factor Xa inhibitor, which is a tetrahydropyrimidin-2(1H)-one derivative. TAK-442 inhibited endogenous FXa activity in platelet-poor human [half-maximal inhibitory concentration (IC(50)): 53 nM, TAK-442] and rat (IC(50): 32 nM, TAK-442) plasma.

More Information Supplier Page